McFerrin Michael B, Sontheimer Harald
Department of Neurobiology and Civitan International Research Center, University of Alabama at Birmingham, USA.
Neuron Glia Biol. 2006 Feb;2(1):39-49. doi: 10.1017/S17440925X06000044.
Many cells, including neuronal and glial progenitor cells, stem cells and microglial cells, have the capacity to move through the extracellular spaces of the developing and mature brain. This is particularly pronounced in astrocyte-derived tumors, gliomas, which diffusely infiltrate the normal brain. Although a significant body of literature exists regarding signals that are involved in the guidance of cells and their processes, little attention has been paid to cell-shape and cell-volume changes of migratory cells. However, extracellular spaces in the brain are very narrow and represent a major obstacle that requires cells to dynamically regulate their volume. Recent studies in glioma cells show that this involves the secretion of Cl(-) and K(+) with water. Pharmacological inhibition of Cl(-) channels impairs their ability to migrate and limits tumor progression in experimental tumor models. One Cl(-)-channel inhibitor, chlorotoxin, is currently in Phase II clinical trials to treat malignant glioma. This article reviews our current knowledge of cell-volume changes and the role of ion channels during the migration of glioma cells. It also discusses evidence that supports the importance of channel-mediated cell-volume changes in the migration of immature neurons and progenitor cells during development. New unpublished data is presented, which demonstrates that Cl(-) and K(+) channels involved in cell shrinkage localize to lipid-raft domains on the invadipodia of glioma cells and that their presence might be regulated by trafficking of these proteins in and out of lipid rafts.
许多细胞,包括神经元和神经胶质祖细胞、干细胞和小胶质细胞,都有能力在发育中和成熟大脑的细胞外空间中移动。这在星形胶质细胞衍生的肿瘤——胶质瘤中尤为明显,胶质瘤会弥漫性浸润正常大脑。尽管已有大量关于参与细胞及其突起导向的信号的文献,但对迁移细胞的细胞形状和细胞体积变化却很少关注。然而,大脑中的细胞外空间非常狭窄,是一个主要障碍,这就要求细胞动态调节其体积。最近对胶质瘤细胞的研究表明,这涉及到氯离子(Cl⁻)和钾离子(K⁺)与水的分泌。对氯离子通道的药理学抑制会损害它们的迁移能力,并限制实验性肿瘤模型中的肿瘤进展。一种氯离子通道抑制剂——氯毒素,目前正处于治疗恶性胶质瘤的II期临床试验阶段。本文综述了我们目前对胶质瘤细胞迁移过程中细胞体积变化和离子通道作用的认识。它还讨论了支持通道介导的细胞体积变化在发育过程中未成熟神经元和祖细胞迁移中的重要性的证据。本文还展示了新的未发表数据,这些数据表明参与细胞收缩的氯离子和钾离子通道定位于胶质瘤细胞侵袭伪足上的脂筏结构域,并且它们的存在可能受这些蛋白质进出脂筏的转运调控。